Safety and Immunogenicity of an Inactivated Pandemic Influenza Vaccine

Clinical trial NCT00535665 · COMPLETED

Trial details

NCT number: NCT00535665
Sponsor: Sinovac Biotech Co., Ltd
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pandemic Influenza Prevention

Start date: 2007-09-01
Enrollment: 402

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.